Vjoncology

Managing the effects of cancer and cancer treatments on patients’ nutritional status 01:46
Managing the effects of cancer and cancer treatments on patients’ nutritional status VJOncology 30 2 года назад
Minimizing immunotherapy-induced toxicity in patients with GI tumors 00:38
Minimizing immunotherapy-induced toxicity in patients with GI tumors VJOncology 150 10 месяцев назад
PFS by clinical factors in the SIENDO trial of selinexor in endometrial cancer 01:55
PFS by clinical factors in the SIENDO trial of selinexor in endometrial cancer VJOncology 42 55 лет назад
The evolving landscape of targeted therapies for RAS-mutated colorectal cancers 01:06
The evolving landscape of targeted therapies for RAS-mutated colorectal cancers VJOncology 20 6 дней назад
Assessing emerging therapies for melanoma brain metastases 01:11
Assessing emerging therapies for melanoma brain metastases VJOncology 0 21 час назад
The role of active surveillance for patients with metastatic kidney cancer 01:24
The role of active surveillance for patients with metastatic kidney cancer VJOncology 21 55 лет назад
Disparities in biomarker-targeted therapy for resected NSCLC 04:05
Disparities in biomarker-targeted therapy for resected NSCLC VJOncology 26 55 лет назад
Phase I study of B440, a WT1 cancer vaccine, in patients with metastatic urothelial cancer 01:40
Phase I study of B440, a WT1 cancer vaccine, in patients with metastatic urothelial cancer VJOncology 47 55 лет назад
PRESERVE-006: gotistobart and 177Lu-PSMA-617 in pre-treated mCRPC 01:51
PRESERVE-006: gotistobart and 177Lu-PSMA-617 in pre-treated mCRPC VJOncology 26 2 дня назад
Understanding treatment approaches for older patients with metastatic pancreatic cancer 02:40
Understanding treatment approaches for older patients with metastatic pancreatic cancer VJOncology 66 4 месяца назад
Important considerations in developing CAR-T cell therapy for GBM 02:05
Important considerations in developing CAR-T cell therapy for GBM VJOncology 33 55 лет назад
Practice-changing CRC cancer trials at ASCO 2025: ATOMIC & CheckMate 8HW 02:37
Practice-changing CRC cancer trials at ASCO 2025: ATOMIC & CheckMate 8HW VJOncology 197 55 лет назад
Optimal sequencing of targeted agents in relation to IO, regorafenib, & TAS-102 for mCRC 01:09
Optimal sequencing of targeted agents in relation to IO, regorafenib, & TAS-102 for mCRC VJOncology 24 6 дней назад
Early Phase I findings for B7-H4-directed ADC Emi-Le in solid tumors 01:50
Early Phase I findings for B7-H4-directed ADC Emi-Le in solid tumors VJOncology 17 7 дней назад
ASTRRA: ovarian function suppression with tamoxifen in HR+ breast cancer 02:52
ASTRRA: ovarian function suppression with tamoxifen in HR+ breast cancer VJOncology 26 55 лет назад
DAREON-9: interim findings of obrixtamig and topotecan in pre-treated SCLC 02:40
DAREON-9: interim findings of obrixtamig and topotecan in pre-treated SCLC VJOncology 44 55 лет назад
SUBITO: IACT vs conventional chemotherapy for HER2-, HRD breast cancer 04:21
SUBITO: IACT vs conventional chemotherapy for HER2-, HRD breast cancer VJOncology 51 7 месяцев назад
How will ctDNA and liquid biopsies be utilized in gynecological cancers? 00:51
How will ctDNA and liquid biopsies be utilized in gynecological cancers? VJOncology 14 7 дней назад
CheckMate 8HW: expanded analysis of nivolumab & ipilimumab in MSI-H/dMMR mCRC 04:38
CheckMate 8HW: expanded analysis of nivolumab & ipilimumab in MSI-H/dMMR mCRC VJOncology 47 55 лет назад
Neoadjuvant therapy for cutaneous squamous cell carcinoma: a promising approach 02:24
Neoadjuvant therapy for cutaneous squamous cell carcinoma: a promising approach VJOncology 45 55 лет назад

Сейчас ищут